APO-TOPIRAMATE 200 MG
TOPIRAMATE : 200 MG · DIN 02279649 · APOTEX INC
Health Canada status: MARKETED
What is APO-TOPIRAMATE?
APO-TOPIRAMATE 200 MG contains TOPIRAMATE : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02279649, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 21-Apr-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is APO-TOPIRAMATE used for?
APO-TOPIRAMATE (topiramate tablets) is indicated as monotherapy for the management of patients (adults and children six years and older) with newly diagnosed epilepsy. It is also indicated as adjunctive therapy for the management of patients (adults and children two years and older) with epilepsy who are not satisfactorily controlled with conventional therapy. APO-TOPIRAMATE is indicated in adults for the prophylaxis of migraine headache.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02279649 |
|---|---|
| Brand name | APO-TOPIRAMATE |
| Generic / active ingredient | TOPIRAMATE : 200 MG |
| Manufacturer | APOTEX INC |
| Strength | 200 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N03AX11 TOPIRAMATE |
| AHFS class | 28:08.92 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 21-Apr-2006 |
| Original market date | 2006-08-09 00:00:00 |
How is it stored and handled?
null
How is it supplied?
Bottles of 100
Is TOPIRAMATE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Anticipated — reported by SANIS HEALTH INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code N03AX11 TOPIRAMATE. 42 of 125 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AG-TOPIRAMATE TABLETS | 100 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02536730 |
| AG-TOPIRAMATE TABLETS | 25 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02536722 |
| APO-TOPIRAMATE | 100 MG | TABLET | APOTEX INC | MARKETED | DIN 02279630 |
| APO-TOPIRAMATE | 25 MG | TABLET | APOTEX INC | MARKETED | DIN 02279614 |
| AURO-TOPIRAMATE | 100 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02345838 |
| AURO-TOPIRAMATE | 200 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02345846 |
| AURO-TOPIRAMATE | 25 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02345803 |
| GLN-TOPIRAMATE | 100 MG | TABLET | GLENMARK PHARMACEUTICALS CANADA INC. | MARKETED | DIN 02287773 |
| GLN-TOPIRAMATE | 200 MG | TABLET | GLENMARK PHARMACEUTICALS CANADA INC. | MARKETED | DIN 02287781 |
| GLN-TOPIRAMATE | 25 MG | TABLET | GLENMARK PHARMACEUTICALS CANADA INC. | MARKETED | DIN 02287765 |
Who else supplies TOPIRAMATE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TOPIRAMATE appears in 443 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.